东诚药业
(002675)
| 流通市值：93.44亿 | | | 总市值：103.65亿 |
| 流通股本：7.43亿 | | | 总股本：8.25亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,308,921,449.19 | 626,367,330.36 | 2,741,074,183.83 | 2,043,088,592.83 |
| 营业总成本 | 1,180,863,080.35 | 577,283,980.83 | 2,521,698,364.08 | 1,862,700,437.32 |
| 其他经营收益 | | | | |
| 营业利润 | 124,641,928.53 | 48,584,595.09 | 212,638,764.73 | 182,448,575.03 |
| 利润总额 | 124,647,888.82 | 48,406,137.03 | 211,442,575.58 | 181,665,295.6 |
| 净利润 | 82,993,349.34 | 34,867,172.49 | 154,441,271.11 | 124,555,089.78 |
| 每股收益 | | | | |
| 其他综合收益 | -30,675,085.83 | -15,147,336.34 | -566,212.92 | -1,998,026.56 |
| 综合收益总额 | 52,318,263.51 | 19,719,836.15 | 153,875,058.19 | 122,557,063.22 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,565,426,766.15 | 2,613,889,566.47 | 2,684,935,912.33 | 2,878,878,277.84 |
| 非流动资产: | | | | |
| 非流动资产合计 | 6,639,666,094.99 | 6,565,078,218.59 | 6,538,825,863.81 | 6,406,478,615.43 |
| 资产总计 | 9,205,092,861.14 | 9,178,967,785.06 | 9,223,761,776.14 | 9,285,356,893.27 |
| 流动负债: | | | | |
| 流动负债合计 | 1,771,953,209.69 | 1,531,092,539.69 | 1,636,007,566.04 | 1,686,474,175.84 |
| 非流动负债: | | | | |
| 非流动负债合计 | 2,100,711,885.73 | 2,243,468,084.68 | 2,124,049,223.47 | 2,153,452,623.16 |
| 负债合计 | 3,872,665,095.42 | 3,774,560,624.37 | 3,760,056,789.51 | 3,839,926,799 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 4,398,152,673.51 | 4,286,341,387.78 | 4,350,054,961.75 | 4,373,160,161.17 |
| 股东权益合计 | 5,332,427,765.72 | 5,404,407,160.69 | 5,463,704,986.63 | 5,445,430,094.27 |
| 负债和股东权益合计 | 9,205,092,861.14 | 9,178,967,785.06 | 9,223,761,776.14 | 9,285,356,893.27 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,263,021,454.85 | 628,686,385.29 | 2,879,154,143.36 | 2,202,991,434.51 |
| 经营活动现金流出小计 | 1,200,736,091.12 | 660,084,916.82 | 2,299,303,748.9 | 1,861,997,106.94 |
| 经营活动产生的现金流量净额 | 62,285,363.73 | -31,398,531.53 | 579,850,394.46 | 340,994,327.57 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 447,462,500.23 | 262,343,044.37 | 1,151,461,823.44 | 897,898,457.79 |
| 投资活动现金流出小计 | 1,058,822,810.84 | 282,296,959.11 | 1,706,136,211.22 | 1,248,820,265.77 |
| 投资活动产生的现金流量净额 | -611,360,310.61 | -19,953,914.74 | -554,674,387.78 | -350,921,807.98 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 912,985,648.92 | 161,889,298.6 | 928,226,113.98 | 914,557,566.61 |
| 筹资活动现金流出小计 | 531,863,480.23 | 161,923,441.83 | 841,905,373.98 | 685,673,135.37 |
| 筹资活动产生的现金流量净额 | 381,122,168.69 | -34,143.23 | 86,320,740 | 228,884,431.24 |
| 汇率变动对现金及现金等价物的影响 | -4,394,515.87 | -2,501,209.53 | -2,391,921.44 | 2,482,833.6 |
| 现金及现金等价物净增加额 | -172,347,294.06 | -53,887,799.03 | 109,104,825.24 | 221,439,784.43 |
| 期末现金及现金等价物余额 | 672,378,096.26 | 793,191,007.2 | 844,725,390.32 | 957,060,349.51 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -172,347,294.06 | - | 109,104,825.24 | - |
最新报告期：2026-09-08| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 天风证券 | 杨松 | 0.24 | 0.31 | 0.38 | 2026-09-08 |
| 平安证券 | 叶寅,韩盟盟 | 0.27 | 0.37 | 0.50 | 2026-08-24 |